Acute Cholesterol-Lowering Effect of Exendin-4 in <i>Ldlr</i><sup>−/−</sup> and C57BL/6J Mice
Mika Hori(Nagoya University Hospital), Mariko Harada‐Shiba(Osaka University of Pharmaceutical Sciences)
Cited by 6
Related Papers
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
|The Lancet Diabetes & Endocrinology|2016|418
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
|European Heart Journal|2023|329
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
|Journal of Atherosclerosis and Thrombosis|2023|269
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177